Altria(US:MO) ZACKSยท2025-05-13 14:35Core Viewpoint - Altria Group Inc. experienced a 2.1% decline in share price following the release of its first-quarter 2025 results, contrasting with slight gains in the broader market and its industry peers [1][6]. Financial Performance - Altria reported first-quarter adjusted earnings per share (EPS) of $1.23, exceeding the Zacks Consensus Estimate of $1.17, reflecting a 6% year-over-year growth [6]. - Net revenues fell by 5.7% to $5.26 billion, primarily due to weaker cigarette shipment volumes [6][9]. - The Zacks Consensus Estimate for Altria's EPS for 2025 and 2026 has increased by 0.8% and 1.1%, respectively, indicating a positive outlook [12]. Market Comparison - Among tobacco peers, Turning Point Brands, Inc. outperformed with a 17.9% return, while Philip Morris International and British American Tobacco saw declines of 2.5% and 3.3%, respectively [2]. - Altria's forward 12-month price-to-earnings (P/E) ratio is 10.51x, significantly lower than the industry average of 14.55x and the S&P 500's average of 20.70x, suggesting it is undervalued [15][16]. Business Segments - Altria's Smokeable Products segment faced revenue softness due to declining shipment volumes, but robust pricing strategies helped mitigate margin erosion [8][9]. - The oral nicotine pouch brand on! saw an 18% increase in shipment volumes, reaching over 39 million cans, and expanded its market share in the nicotine pouch segment to 17.9% [10]. - The e-vapor segment faced challenges with the discontinuation of NJOY ACE, resulting in a non-cash impairment charge of $873 million, but the company remains committed to innovation in this space [11]. Investor Sentiment - The divergence between solid earnings performance and stock price weakness raises questions about whether the pullback is a short-term overreaction or a long-term buying opportunity [7]. - Altria's defensive business model and attractive valuation make it a stable investment option, especially for value-focused investors [19].